KBC Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
KBC Group's CNMD Position: Q3 2026 in Review
KBC Group held its CONMED (CNMD) position steady in Q3 2026 at 899 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.
KBC Group first reported a position in CNMD in Q2 2019 and has held it in 30 quarters since. The position peaked at $2.12M in Q4 2019. 270 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.
- KBC Group held 899 shares of CONMED worth $42K as of Q3 2026.
- KBC Group left its CONMED share count unchanged in Q3 2026.
- CONMED made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1757 holding.
- KBC Group first reported a position in CONMED in Q2 2019 and has held it in 30 quarters since.
- KBC Group's CONMED position peaked at $2.12M in Q4 2019.
- 270 funds tracked by Wall St. Rank held CONMED as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.